Abstract
Introduction Speech is a promising marker for schizophrenia-spectrum disorder diagnosis, as it closely reflects symptoms. Previous approaches have made use of different feature domains of speech in classification, including semantic and phonetic features. However, an examination of the relative contribution and accuracy per domain remains an area of active investigation. Here, we examine these domains (i.e. phonetic and semantic) separately and in combination.
Methods Using a semi-structured interview with neutral topics, speech of 94 schizophrenia-spectrum subjects (SSD) and 73 healthy controls (HC) was recorded. Phonetic features were extracted using a standardized feature set, and transcribed interviews were used to assess word connectedness using a word2vec model. Separate cross-validated random forest classifiers were trained on each feature domain. A third, combinatory classifier was used to combine features from both domains.
Results The phonetic domain random forest achieved 81% accuracy in classifying SSD from HC. For the semantic domain, the classifier reached an accuracy of 80% with a sparse set of features with 10-fold cross-validation. Joining features from the domains, the combined classifier reached 85% accuracy, significantly improving on models trained on separate domains. Top features were fragmented speech for phonetic and variance of connectedness for semantic, with both being the top features for the combined classifier.
Discussion Both semantic and phonetic domains achieved similar results compared with previous research. Combining these features shows the relative value of each domain, as well as the increased classification performance from implementing features from multiple domains. Explainability of models and their feature importance is a requirement for future clinical applications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical review board of the University Medical Center Utrecht gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Anonymous data produced in the present study are available upon reasonable request to the authors